ClinicalTrials.Veeva

Menu

Blood Pressure Estimation Using Noninvasive Biosignals During Pediatric Anesthesia

Seoul National University logo

Seoul National University

Status

Unknown

Conditions

Pediatrics
Electrocardiography
Accelerometer
Blood Pressure

Treatments

Device: Biosignal measurements

Study type

Observational

Funder types

Other

Identifiers

NCT04087070
H-1907-088-1049

Details and patient eligibility

About

The aim of this study is to estimate blood pressure in pediatric patients using a non-invasive electrocardiogram (ECG), photoplethysmograph (PPG), and an accelerometer on the chest.

Full description

Blood pressure is measured by an automated oscillometric device or arterial waveform from IntelliVue MX800 Bedside patient monitor (Philips Healthcare, Amsterdam, Netherlands).

Following parameters will be measured by non-invasive electrocardiogram (ECG), photoplethysmograph (PPG), and an accelerometer on the chest and will be used to estimate the biosignal derived blood pressure.

  1. PAT(time between R peak of ECG and beginning of the pulse of PPG)
  2. PEP(time between R peak of ECG and peak of accelerometer signal)
  3. PTT(PAT-PEP)

The algorithm of the biosignal derived blood pressure will be made using the MATLAB 2016b(Mathworks, Natick, MA) program.

The agreement between the non-invasive blood pressure and the biosignal derived blood pressure will be analyzed using Cohen's Kappa or Bland-Altman plot.

Enrollment

100 estimated patients

Sex

All

Ages

Under 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA(American Society of Anesthesiologist) Class I, II
  • Scheduled for elective surgery under general anesthesia

Exclusion criteria

  • History of cardiovascular disease
  • History of thoracic cavity disease
  • Unable to measure blood pressure

Trial design

100 participants in 1 patient group

biosignal derived blood pressure
Description:
Blood pressure is measured by an automated oscillometric device or arterial waveform from IntelliVue MX800 Bedside patient monitor (Philips Healthcare, Amsterdam, Netherlands). Following parameters will be measured by non-invasive electrocardiogram (ECG), photoplethysmograph (PPG), and an accelerometer on the chest and will be used to estimate the biosignal derived blood pressure. 1. PAT(time between R peak of ECG and beginning of the pulse of PPG) 2. PEP(time between R peak of ECG and peak of accelerometer signal) 3. PTT(PAT-PEP)
Treatment:
Device: Biosignal measurements

Trial contacts and locations

1

Loading...

Central trial contact

Hee-Soo Kim, MD.PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems